EORTC abstracts selected at EBCC-12 Virtual Congress
28 Sep 2020
3 EORTC abstracts were selected for the 12th European Breast Cancer Conference (EBCC-12) that will take place virtually on 2-3 October 2020.
Plenary Session
Keynote Lecture, Best and Late Breaking Abstract Presentations
Clinical Utility of MammaPrint testing in Invasive Lobular Carcinoma: Results from the MINDACT phase III trial
- Presentation number: ORAL-007
- Date: 2 October 2020, 13:50-14:00
- Speaker: Otto Metzger (USA)
Proffered Papers Session
Updated results of the MINDACT trial: 70-gene signature to guide de-escalation of chemotherapy in early breast cancer
- Presentation number: ORAL-021
- Date: 3 October 2020, 13:00-13:10
- Speaker: Emiel Rutgers (The Netherlands)
Screen-detected breast cancers have different tumor biology and better prognosis compared to interval breast cancers
- Presentation number: ORAL-011
- Date: 3 October 2020, 12:50-13:00
- Speaker: Josephine Lopes Cardozo (The Netherlands)
- MINDACT: 70-gene signature test as guidance for breast cancer treatment – video interview of Josephine Lopes Cardoso (source: ecancer)
EBCC-12 is a breast cancer conference where the very latest practice-changing research is presented. It aims to provide a unique multidisciplinary setting for all professionals with a common interest in breast cancer to discuss, debate, inform and educate themselves about this evolving disease.
To view the full two day programme, visit the EBCC-12 searchable programme.
Registration for the virtual event is still open. For further information click here.
Related News
Meet the new EORTC Board
9 Jul 2024
We are pleased to announce the release of the EORTC 2023 Annual Report
17 Jun 2024
Dr Denis Lacombe, EORTC CEO, appointed stakeholder co-chair of ACT EU advisory group
24 May 2024
Clinical Trials Day 2024: a Q&A on pragmatic clinical trials
20 May 2024
EORTC/EMA workshop suggests an international way forward for treatment optimisation studies
8 May 2024
EORTC’s Participation at the ESTRO Congress 2024
29 Apr 2024
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024